- Report
- August 2024
- 138 Pages
Global
From €2726EUR$2,999USD£2,315GBP
- Report
- April 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- May 2024
- 185 Pages
Global
From €4090EUR$4,500USD£3,473GBP
- Report
- December 2024
- 150 Pages
Global
From €3409EUR$3,750USD£2,894GBP
- Report
- January 2025
Global
From €6817EUR$7,500USD£5,789GBP
- Report
- January 2025
- 429 Pages
Global
From €4499EUR$4,950USD£3,821GBP
- Report
- October 2024
- 183 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- March 2025
- 181 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- November 2024
- 183 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 194 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 191 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 180 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 197 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 188 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- October 2024
- 186 Pages
Global
From €3222EUR$3,545USD£2,736GBP
€3580EUR$3,939USD£3,040GBP
- Report
- February 2025
- 200 Pages
Global
From €4081EUR$4,490USD£3,466GBP
- Report
- March 2025
- 147 Pages
Global
From €2726EUR$2,999USD£2,315GBP
- Report
- August 2024
- 146 Pages
Global
From €2726EUR$2,999USD£2,315GBP
- Report
- July 2024
- 143 Pages
Global
From €2726EUR$2,999USD£2,315GBP
- Report
- December 2024
- 150 Pages
Global
From €5408EUR$5,950USD£4,592GBP

Cardiac Resynchronization (CRT) is a type of cardiovascular device used to treat heart failure. It is a therapy that uses electrical stimulation to synchronize the contractions of the left and right ventricles of the heart. This helps to improve the heart's pumping efficiency and reduce symptoms of heart failure. CRT is typically used in combination with other treatments such as medications, lifestyle changes, and implantable cardioverter-defibrillators (ICDs).
CRT devices are typically implanted in the chest and consist of a pulse generator, leads, and electrodes. The pulse generator sends electrical signals to the heart through the leads and electrodes, which are connected to the left and right ventricles. The electrical signals help to coordinate the contractions of the ventricles, improving the heart's pumping efficiency.
CRT is a rapidly growing market, with a wide range of products available from various manufacturers. Companies in the market include Medtronic, Abbott, Boston Scientific, Biotronik, and St. Jude Medical. Show Less Read more